ANTISENSE MODULATION OF CALRETICULIN EXPRESSION

Details for Australian Patent Application No. 2002245132 (hide)

Owner ISIS PHARMACEUTICALS, INC. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Inventors ROTHLEIN, Robert; COWSERT, Lex, M.; KISHIMOTO, Takashi, Kei; BENNETT, C., Frank

Pub. Number AU-A-2002245132

PCT Pub. Number WO2002/068688

Priority 09/791,406 22.02.01 US

Filing date 30 October 2001

Wipo publication date 12 September 2002

International Classifications

C12N 015/85 Mutation or genetic engineering - for animal cells

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002245132

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245133-METHODS OF PRODUCING POLYKETIDE SYNTHASE MUTANTS AND COMPOSITIONS AND USES THEREOF

2002245131-METHOD AND APPARATUS FOR RAPIDLY STERILIZING SMALL OBJECTS